• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雾化吸入妥布霉素制剂和生理盐水后囊性纤维化患者的支气管收缩

Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.

作者信息

Nikolaizik W H, Jenni-Galović V, Schöni M H

机构信息

Alpine Children's Hospital, Davos Platz, Switzerland.

出版信息

Eur J Pediatr. 1996 Jul;155(7):608-11. doi: 10.1007/BF01957914.

DOI:10.1007/BF01957914
PMID:8831087
Abstract

UNLABELLED

To assess the airway response to inhaled tobramycin we measured flow volume curves in 12 patients with cystic fibrosis. Immediately and/or 2 min after tobramycin inhalations there was a significant fall in lung function regardless of the concentration used; isotonic saline caused similar obstruction but not a complete cessation of peripheral airflows. The baseline oxygen saturation was significantly correlated with the fall in lung function. Ten minutes after inhalation lung function tests returned to baseline values.

CONCLUSION

As salbutamol could significantly reduce airway obstruction tobramycin should always be inhaled in combination with a bronchodilator.

摘要

未标注

为评估吸入妥布霉素后的气道反应,我们对12例囊性纤维化患者测量了流量-容积曲线。无论使用何种浓度,在吸入妥布霉素后即刻和/或2分钟时,肺功能均显著下降;等渗盐水也会导致类似的阻塞,但不会使外周气流完全停止。基线氧饱和度与肺功能下降显著相关。吸入后10分钟,肺功能测试恢复到基线值。

结论

由于沙丁胺醇可显著减轻气道阻塞,妥布霉素应始终与支气管扩张剂联合吸入。

相似文献

1
Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.雾化吸入妥布霉素制剂和生理盐水后囊性纤维化患者的支气管收缩
Eur J Pediatr. 1996 Jul;155(7):608-11. doi: 10.1007/BF01957914.
2
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis.
Eur Respir J. 2002 Jul;20(1):122-6. doi: 10.1183/09031936.02.00264002.
3
Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.雾化吸入高浓度妥布霉素对铜绿假单胞菌定植的囊性纤维化患者的疗效、安全性及局部药代动力学研究
Paediatr Drugs. 2007;9 Suppl 1:11-20. doi: 10.2165/00148581-200709001-00003.
4
Tobramycin inhalation solution (Bethkis) for cystic fibrosis.
Med Lett Drugs Ther. 2014 Jun 23;56(1445):51-2.
5
A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.雾化妥布霉素(Bramitob)制剂治疗囊性纤维化合并铜绿假单胞菌感染患者:一项双盲、安慰剂对照、多中心研究。
Paediatr Drugs. 2007;9 Suppl 1:21-31. doi: 10.2165/00148581-200709001-00004.
6
Tobramycin dosing in cystic fibrosis.
Lancet. 2005;365(9473):1767-8. doi: 10.1016/S0140-6736(05)66577-4.
7
Effect of Inspiratory Maneuvers on Lung Deposition of Tobramycin Inhalation Powder: A Modeling Study.吸气动作对妥布霉素吸入粉肺部沉积的影响:建模研究。
J Aerosol Med Pulm Drug Deliv. 2020 Apr;33(2):61-72. doi: 10.1089/jamp.2019.1529. Epub 2020 Feb 19.
8
Single daily tobramycin dosing in cystic fibrosis: is it better for the patients or the bugs?
Lancet. 2005;365(9459):547-8. doi: 10.1016/S0140-6736(05)17919-7.
9
Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.囊性纤维化患者的急性肾衰竭:与吸入用妥布霉素治疗的关联。
Pediatr Pulmonol. 2002 Nov;34(5):375-7. doi: 10.1002/ppul.10185.
10
Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.用于囊性纤维化的妥布霉素吸入粉(托比吸乐)
Med Lett Drugs Ther. 2013 Jun 24;55(1419):51-2.

引用本文的文献

1
Short-term Tolerance to Inhaled Antibiotics in Patients With Bronchial Infection not Associated With Cystic Fibrosis.非囊性纤维化支气管感染患者对吸入性抗生素的短期耐受性
Open Respir Arch. 2025 Jun 24;7(3):100460. doi: 10.1016/j.opresp.2025.100460. eCollection 2025 Jul-Sep.
2
Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.吸入性抗假单胞菌抗生素用于囊性纤维化的长期治疗。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD001021. doi: 10.1002/14651858.CD001021.pub4.
3
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.

本文引用的文献

1
Efficacy of aerosolized tobramycin in patients with cystic fibrosis.雾化妥布霉素对囊性纤维化患者的疗效。
N Engl J Med. 1993 Jun 17;328(24):1740-6. doi: 10.1056/NEJM199306173282403.
2
Comparison of efficacy of salbutamol and sodium cromoglycate in the prevention of ticarcillin-induced bronchoconstriction.沙丁胺醇与色甘酸钠预防替卡西林所致支气管收缩疗效的比较。
Pediatr Pulmonol. 1993 Nov;16(5):311-5. doi: 10.1002/ppul.1950160507.
3
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
吸入抗生素治疗囊性纤维化肺部加重。
Cochrane Database Syst Rev. 2022 Aug 1;8(8):CD008319. doi: 10.1002/14651858.CD008319.pub4.
4
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler.优化喷雾干燥多孔颗粒以通过便携式干粉吸入器实现高剂量给药。
Pharmaceutics. 2021 Sep 21;13(9):1528. doi: 10.3390/pharmaceutics13091528.
5
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.吸入性抗生素用于囊性纤维化患者的肺部加重期
Cochrane Database Syst Rev. 2018 Oct 30;10(10):CD008319. doi: 10.1002/14651858.CD008319.pub3.
6
Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.吸入性抗假单胞菌抗生素用于囊性纤维化的长期治疗。
Cochrane Database Syst Rev. 2018 Mar 30;3(3):CD001021. doi: 10.1002/14651858.CD001021.pub3.
7
Long-acting inhaled bronchodilators for cystic fibrosis.用于囊性纤维化的长效吸入型支气管扩张剂。
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD012102. doi: 10.1002/14651858.CD012102.pub2.
8
Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation.通过经吸入给予的不含防腐剂的静脉用妥布霉素来降低吸入用妥布霉素的成本。
Antibiotics (Basel). 2015 Dec 29;5(1):2. doi: 10.3390/antibiotics5010002.
9
A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.雾化妥布霉素(Bramitob)制剂治疗囊性纤维化合并铜绿假单胞菌感染患者:一项双盲、安慰剂对照、多中心研究。
Paediatr Drugs. 2007;9 Suppl 1:21-31. doi: 10.2165/00148581-200709001-00004.
雾化羧苄青霉素和庆大霉素治疗囊性纤维化患者的铜绿假单胞菌感染
Lancet. 1981 Nov 21;2(8256):1137-9. doi: 10.1016/s0140-6736(81)90588-2.
4
Standardization of spirometry--1987 update. Statement of the American Thoracic Society.肺量计标准化——1987年更新版。美国胸科学会声明
Am Rev Respir Dis. 1987 Nov;136(5):1285-98. doi: 10.1164/ajrccm/136.5.1285.
5
Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics.囊性纤维化中的气道阻塞与气道壁不稳定:茶碱与拟交感神经药的单独及联合作用
Pediatr Pulmonol. 1988;4(4):205-12. doi: 10.1002/ppul.1950040404.
6
Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
Pediatr Pulmonol. 1989;7(1):42-8. doi: 10.1002/ppul.1950070110.
7
Bronchial response to nebulized antibiotics in children with cystic fibrosis.囊性纤维化患儿对雾化抗生素的支气管反应。
Eur Respir J. 1990 Nov;3(10):1114-6.
8
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.肺功能测试:参考值的选择与解读策略。美国胸科学会。
Am Rev Respir Dis. 1991 Nov;144(5):1202-18. doi: 10.1164/ajrccm/144.5.1202.
9
Spirometry in the evaluation of pulmonary function.肺功能评估中的肺量计检查
West J Med. 1976 Aug;125(2):110-8.